These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36741559)

  • 21. Sex difference in association between insomnia and cognitive impairment in patients with chronic schizophrenia.
    Zhu R; Wang D; Tian Y; Du Y; Chen J; Zhou H; Chen D; Wang L; Alonzo BA; Emily Wu H; Yang Zhang X
    Schizophr Res; 2022 Feb; 240():143-149. PubMed ID: 35026599
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence and Clinical Correlates of and Cognitive Function at the Time of Suicide Attempts in First-Episode and Drug-Naive Patients With Schizophrenia.
    Zhang XY; Du X; Yin G; Zhang Y; Chen D; Xiu M; Wang C; Zhang R; Cassidy RM; Ning Y; Huang X; Soares JC
    J Clin Psychiatry; 2018 Jul; 79(4):. PubMed ID: 30063302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gender differences in never-medicated first-episode schizophrenia and medicated chronic schizophrenia patients.
    Zhang XY; Chen DC; Xiu MH; Yang FD; Haile CN; Kosten TA; Kosten TR
    J Clin Psychiatry; 2012 Jul; 73(7):1025-33. PubMed ID: 22901352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased Plasma Levels of Growth Differentiation Factor 11 in Patients With Schizophrenia: Correlation With Psychopathology and Cognition.
    Yang ZX; Zhan JQ; Xiong JW; Wei B; Fu YH; Liu ZP; Tu YT; Yang YJ; Wan AL
    Front Psychiatry; 2020; 11():555133. PubMed ID: 33364986
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Decreased Peripheral BDNF Levels and Cognitive Impairment in Late-Life Schizophrenia.
    Huo L; Zheng Z; Lu X; Wu F; Ning Y; Zhang XY
    Front Psychiatry; 2021; 12():641278. PubMed ID: 34239458
    [No Abstract]   [Full Text] [Related]  

  • 27. Cigarette smoking and cognitive function in Chinese male schizophrenia: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Haile CN; Sun H; Lu L; Kosten TA; Kosten TR
    PLoS One; 2012; 7(5):e36563. PubMed ID: 22570726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trajectory classes of violent behavior and their relationship to lipid levels in schizophrenia inpatients.
    Chen SC; Chu NH; Hwu HG; Chen WJ
    J Psychiatr Res; 2015; 66-67():105-11. PubMed ID: 26004299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cross-sectional assessment of the factors associated with occupational functioning in patients with schizophrenia.
    Li N; Ying C; Deng H
    Shanghai Arch Psychiatry; 2012 Aug; 24(4):222-30. PubMed ID: 25324630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender Difference in Cognitive Function Among Stable Schizophrenia: A Network Perspective.
    Chen M; Zhang L; Jiang Q
    Neuropsychiatr Dis Treat; 2022; 18():2991-3000. PubMed ID: 36578902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Preventing violence in schizophrenia with cognitive remediation].
    Darmedru C; Demily C; Franck N
    Encephale; 2018 Apr; 44(2):158-167. PubMed ID: 28641817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gender differences of neurocognitive functioning in patients with first-episode schizophrenia in China.
    Pu C; Qiu Y; Zhou T; Yang F; Lu Z; Wang C; Deng H; Zhao J; Shi C; Yu X
    Compr Psychiatry; 2019 Nov; 95():152132. PubMed ID: 31669790
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia.
    Guo H; Ye H; Li Z; Li X; Huang W; Yang Y; Xie G; Xu C; Li X; Liang W; Jing H; Zhang C; Tang C; Liang J
    BMC Psychiatry; 2023 Apr; 23(1):231. PubMed ID: 37020192
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
    Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
    Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brief cognitive assessment in schizophrenia: normative data for the Repeatable Battery for the Assessment of Neuropsychological Status.
    Wilk CM; Gold JM; Humber K; Dickerson F; Fenton WS; Buchanan RW
    Schizophr Res; 2004 Oct; 70(2-3):175-86. PubMed ID: 15329294
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Battery for assessment of neuropsychological status (RBANS) in schizophrenia: a pilot study in the Spanish population.
    Sanz JC; Vargas ML; Marín JJ
    Acta Neuropsychiatr; 2009 Feb; 21(1):18-25. PubMed ID: 25384525
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Affective symptoms in schizophrenia are strongly associated with neurocognitive deficits indicating disorders in executive functions, visual memory, attention and social cognition.
    Kanchanatawan B; Thika S; Anderson G; Galecki P; Maes M
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):168-176. PubMed ID: 28666826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia I: sensitivity, reliability, and validity.
    Gold JM; Queern C; Iannone VN; Buchanan RW
    Am J Psychiatry; 1999 Dec; 156(12):1944-50. PubMed ID: 10588409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insight in inpatients with schizophrenia: relationship to symptoms and neuropsychological functioning.
    Zhou Y; Rosenheck R; Mohamed S; Zhang J; Chang Q; Ou Y; Sun B; Ning Y; He H
    Schizophr Res; 2015 Feb; 161(2-3):376-81. PubMed ID: 25533592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical symptoms and cognitive impairment associated with male schizophrenia relate to plasma manganese superoxide dismutase activity: a case-control study.
    Zhang XY; Chen DC; Xiu MH; Tan YL; Yang FD; Zhang LY; Zhang LY; Haile CN; Kosten TR
    J Psychiatr Res; 2013 Aug; 47(8):1049-53. PubMed ID: 23611682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.